StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.39−0.96 (-1.95%)

Close on Nov 17, 2026Market cap $1.44BP/E 20.0Yield 1.24%

Conmed pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Conmed's pe ratio was 27.4× on Nov 11, 2026, against 21.2× a year earlier. Over the last 5 years it ranged from 11.6× to 440.5×, with a median of 30.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202627.4×+7.6
2025Dec 31, 202519.8×+3.5
2024Dec 31, 202416.3×−42.6
2023Dec 29, 202358.9×+12.4
2022Jul 29, 202246.5×−24.4
2021Dec 31, 202170.9×−3.5
2020Jul 31, 202074.4×−37.5
2019Dec 31, 2019111.8×+86.4
2018Dec 31, 201825.5×−65.5
2017Dec 29, 201791.0×+12.1
2016Dec 30, 201678.9×+43.1
2015Dec 31, 201535.8×−4.7
2014Dec 31, 201440.5×+7.6
2013Dec 31, 201332.9×−182.1
2012Dec 31, 2012215.0×+192.5
2011Dec 30, 201122.5×−40.4
2010Dec 31, 201062.9×–

More Conmed figures

See a number that looks wrong?